Healthy Lifestyle

Archive for the ‘Mesothelioma Information’ Category

Mesothelioma and its partner disease, asbestosis, are not limited to any one person or any one nation. Asbestos and asbestos products have been mined and manufactured, and sought after and sold, in nations around the world. The latent diseases of asbestosis and its cancerous partner, mesothelioma, are slowly developing into a world-wide epidemic.

Mesothelioma and asbestosis diseases have been clearly defined as being attributed to asbestos exposure. Despite these undisputable findings, world production of asbestos has risen from 2.18 million metric tons in 2006 to 2.20 million metric tons in 2007, according to the US Government’s 2007 Minerals Handbook. The International World has yet to agree upon and abide by a universal consensus of asbestos safety levels. As some countries ban the use of asbestos, others continue to seek safe exposure levels, and yet others disregard the impending health epidemic. Many smaller nations continue to ignore the perilous diseases of asbestos, while asbestos workers may or may not be aware of their life-risking work environments. Even advanced nations fail to implement protection and procedures to protect workers exposed to asbestos for fear of substantial economic loss.

Even though the European Union banned asbestos in 2005, European companies still have financial interest in companies located in Africa, Canada and South America. Canada has been one of the world’s largest asbestos producers, however they only use 29% of what they produce, and aggressive sales efforts are targeted towards Asia, Africa and South America. In Japan, local factory and building inspections failed to identify asbestos in more than half of the buildings inspected. Even with occupational laws in place, India and China fail to protect the majority of their asbestos workers.

The leaders of asbestos production, Russia, China, Kazakhstan, Brazil, Canada, and Zimbabwe, are responsible for 96% of the world’s asbestos production. In China, the world’s second largest asbestos producer, a significant portion of asbestos workers work without any protection in environments conducive to asbestosis and mesothelioma production. China not only fails to protect its workers from asbestosis and mesothelioma on a mass scale, but their asbestos producing factories are typically located near heavily populated cities. The effects of asbestos exposure and the incidences of asbestosis and mesothelioma are vastly unreported in highly populated areas due to lack of medical records, non-existent laws mandating lengthy medical record-keeping standards, and political interference.

Asbestosis and Mesothelioma are devastating diseases that can affect men, women and children that are exposed to asbestos. It is up to the socially responsible individuals and corporations to continue their advocacy work to protect hard working men and women from the incapacitating diseases of asbestosis and mesothelioma. With the prevalence of asbestos exposure that still exists, there is little doubt that asbestosis and mesothelioma will continue to develop well into the next century. The deadly misfortune of the disease on hardworking individuals can only be eradicated with an end to the demand for asbestos containing products.

Pleural mesothelioma diagnosis is typically met with the striking news that a patient has less than a year or two to live. Early diagnosis of pleural mesothelioma can increase the likelihood of effective treatment. Identifying a level of protein from a specific gene might just be the key to early mesothelioma treatment.

Pleural mesothelioma is significantly more alarming than other asbestos-caused diseases such as asbestosis because of the high risk of death that comes along with the diagnosis of this cancer. However, the short life span that follows mesothelioma is often a result of its late diagnosis. If this asbestos caused cancer were to be diagnosed earlier, then potentially life-saving treatment could begin earlier.

Pleural mesothelioma and asbestosis are lung diseases that produce symptoms similar to hundreds of other potential respiratory illnesses and cancers. Although a history of working with asbestos is a strong indicator that asbestos may be the cause of a patientâ??s lung disease, many patients fail to mention their working history to their physicians, and many physicians dismiss the possibility of asbestos related disease because of its low reported statistics. These statistics, however, are vastly under-reported, as many countries do not have the access to the medical knowledge, equipment, or personnel to correctly determine and report asbestos-caused diseases. Asbestos use continues to thrive around the world, and the incidences of asbestos caused cancer and asbestosis will continue to thrive as well.

Medial researchers are trying to prepare for the future epidemic of asbestos illnesses that the asbestos workers of today will be suffering from in the upcoming decades. Although a cure for pleural mesothelioma is far off in the distance, medical researchers have found that a protein gene identified as osteoprontin exists in patients with this disease and their serum osteoprontin levels are six times higher than other lung disease patients. Osteoprontin is typically associated with the bones since it is a protein located in the bones. However, the gene is an active participant and an important player in bone remodeling, wound healing, and the immune system. The University of Bristol in the UK also found that the gene needs to be suppressed to prevent dangerous scarring of internal tissues and have begun to work on a gel to speed up wound healing that facilitates this suppression.

For patients suffering from undiagnosed respiratory illnesses, identifying an increase in serum osteoprontin can distinguish asbestos cancer from asbestosis or lung cancer. This will save years of unnecessary testing and expenses, provide the opportunity for early cancer treatment, and even increase the swiftness of processing asbestos workersâ?? compensation claims.

Pleural mesothelioma research, medical research on asbestosis, and medical research on other asbestos-related diseases continues to contribute valuable findings that can contribute to improving care and provide valuable medical insights that can be applied within multiple medical fields. Soluble mesothelin-related peptide is similar to osteoprontin, and is also a unique identifier of mesothelioma. Accessible medical access that can test individuals for both of these unique markers can have a significant impact on the health and longevity of todayâ??s asbestos workers. Lung diseases may soon be more easily differentiated. But that isnâ??t enough. Medical accessibility must be improved around the world so todayâ??s asbestos workers can get the early treatment they need to survive.

Medical records that pertain to asbestosis or mesothelioma must be dug up from the archives of the past. Without medical record collections and retrievals, the forewarnings of impending asbestosis and mesothelioma come only from witnessing the sufferings of an asbestosis patient or the languishing death of a mesothelioma cancer patient.

Asbestosis and mesothelioma statistics are sharply under-estimated due to the lack of many nations to implement an efficient medical retrieval system and properly care for and diagnose lung disease patients who are suffering from asbestosis or mesothelioma due to asbestos exposure. In many nations, physicians that are able to properly diagnose the disease are rarely, if ever, available. These same nations often have poor record keeping systems in place to monitor health trends and examine medical histories. Many times asbestosis and mesothelioma are simply referenced as “lung disease,” without a proper determination of the classification of lung disease.

Years pass before these progressive lung diseases start showing their scarring presence, but an archive of medical history can facilitate proper diagnosis, and national archives of medical histories can facilitate early warnings. Despite this knowledge, India has no cancer registry, nor does it have a system for recording mesothelioma and asbestosis cases. In the Philippines, the Occupational Safety and Health Center (OSHC) reports that asbestos caused diseases will be under diagnosed due to low employer participation in submitting medical records to a central agency. (Less than 5% of employers do so.)

In Brazil, where corporations scurry to cover any implications of occupational hazards or ill will, medical records are virtually non-existent for asbestos workers. The Eternit asbestos plant in Brazil has had asbestos workers for over 50 years, yet no medical records were ever kept prior to 1978. In China, death records are purged and permanently eliminated after death, leaving no source for documenting trends in deaths or comparisons and similarities between diseases. And although China is one of the top five asbestos producers and users in the world, this nation continues to have a minimal amount of empirical studies on the implications of asbestos exposure.

Fortunately, in many nations, allowable exposure limits are being reduced, inspections are being heightened, and politicians and corporations are being pressured. Environmental groups and protection agencies continue to test asbestos material and promote its eventual ban. Unfortunately, politics and corporations still govern irresponsible asbestos promotions, and millions of innocent people are unaware of its dangers. The lack of public awareness has led to a deadly economic dependency on asbestos.

Asbestosis and mesothelioma deaths need to be recorded, death records need to be maintained, and medical histories of asbestos workers need to be compiled to gain a full realization of the statistical and economical impact of the world’s burgeoning asbestosis and mesothelioma crisis. Asbestosis and mesothelioma records are useless, however, unless they are used to promote change and develop public awareness – which is precisely what the mining and trading nations are afraid of.